NICE have updated their Melanoma: assessment and management guideline [NG14] – 27 July 2022

This guideline covers the assessment and management of melanoma (a type of skin cancer) in children, young people and adults. It aims to reduce variation in practice and improve survival.

In July 2022, they made new and updated recommendations on genetic testing, staging, surgery for stages 0 to III melanoma, anticancer treatment for people with stage III and IV melanoma, and follow-up.

You can find out more and read the updated guideline here.

This guideline includes recommendations on:

  • Communication and support
  • Managing vitamin D levels and drug treatment for other conditions
  • Assessing and staging melanoma
  • Managing stages 0 to II melanoma
  • Managing stage III melanoma
  • Treating in-transit metastases in stages III and IV melanoma
  • Managing stage IV and unresectable stage III melanoma
  • Follow-up treatment